Kelly Thomas Patrick
Chief Financial Officer
PurchaseAlert
- Shares
- 15,000
- Price
- $37.32
- Value
- $559,740
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•32 filings
XENE
Xenon Pharmaceuticals Inc.
Net purchases of $614.8K over the last 3 months
2 buyers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 2 CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
+$614,761
2 buyers · 2 sellers
12-month purchases
$1,681,140
2 distinct insiders
12-month sales
$20,279,494
3 distinct insiders
Highlighted alerts
3
18 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
2 executive purchases found
Get XENE insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
XENE overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
21
Voluntary view
P/S trades after deterministic checks
79
Administrative noise
Stored, never alerted
51
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 1,322
- Price
- $53.14
- Footnotes
- 2
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on August 17, 2025, solely to satisfy income tax obligations related to the vesting of RSUs granted on June 5, 2025. By Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding. The trade is reported under a Rule 10b5-1 plan.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
MORTIMER IAN
PRESIDENT & CEO
PurchaseAlert
- Shares
- 30,000
- Price
- $37.38
- Value
- $1,121,400
KENNEY CHRISTOPHER JOHN
Chief Medical Officer
Sale 10b5-1
- Shares
- 700
- Price
- $60.98
- Value
- $42,684
KENNEY CHRISTOPHER JOHN
Chief Medical Officer
Sale 10b5-1
- Shares
- 6,368
- Price
- $60.17
- Value
- $383,145
GANNON STEVEN
Director
SaleAlert
- Shares
- 10,000
- Price
- $64.06
- Value
- $640,550
MORTIMER IAN
PRESIDENT & CEO
Sale 10b5-1
- Shares
- 43,348
- Price
- $59.26
- Value
- $2,568,802
MORTIMER IAN
PRESIDENT & CEO
Sale 10b5-1
- Shares
- 2,449
- Price
- $61.26
- Value
- $150,026
MORTIMER IAN
PRESIDENT & CEO
Sale 10b5-1
- Shares
- 10,072
- Price
- $60.47
- Value
- $609,054
MORTIMER IAN
PRESIDENT & CEO
Sale 10b5-1
- Shares
- 12,479
- Price
- $59.50
- Value
- $742,501
MORTIMER IAN
PRESIDENT & CEO
Sale 10b5-1
- Shares
- 21,515
- Price
- $60.49
- Value
- $1,301,442
MORTIMER IAN
PRESIDENT & CEO
Sale 10b5-1
- Shares
- 31,694
- Price
- $59.88
- Value
- $1,897,837
MORTIMER IAN
PRESIDENT & CEO
Sale 10b5-1
- Shares
- 65,000
- Price
- $62.06
- Value
- $4,033,900
MORTIMER IAN
PRESIDENT & CEO
Sale 10b5-1
- Shares
- 61,652
- Price
- $60.08
- Value
- $3,704,052
MORTIMER IAN
PRESIDENT & CEO
Sale 10b5-1
- Shares
- 21,791
- Price
- $58.81
- Value
- $1,281,529
MORTIMER IAN
PRESIDENT & CEO
Sale 10b5-1
- Shares
- 2,062
- Price
- $44.93
- Value
- $92,646
MORTIMER IAN
PRESIDENT & CEO
Sale 10b5-1
- Shares
- 37,938
- Price
- $44.40
- Value
- $1,684,447
MORTIMER IAN
PRESIDENT & CEO
Sale 10b5-1
- Shares
- 2,010
- Price
- $46.32
- Value
- $93,103
MORTIMER IAN
PRESIDENT & CEO
Sale 10b5-1
- Shares
- 8,820
- Price
- $45.59
- Value
- $402,104
MORTIMER IAN
PRESIDENT & CEO
Sale 10b5-1
- Shares
- 14,375
- Price
- $45.03
- Value
- $647,306
MORTIMER IAN
PRESIDENT & CEO
Sale 10b5-1
- Shares
- 97
- Price
- $45.01
- Value
- $4,366
MORTIMER IAN
PRESIDENT, CEO & INTERIM CFO
Sale 10b5-1
- Shares
- 25,000
- Price
- $40.16
- Value
- $1,004,000
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Kelly Thomas Patrick Chief Financial Officer | Purchase | 15,000 | $37.32 | $559,740 | |
| Sep 30, 2026 | MORTIMER IAN PRESIDENT & CEO | Purchase | 30,000 | $37.38 | $1,121,400 | |
| Aug 28, 2026 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Sale | 700 | $60.98 | $42,684 | |
| Aug 28, 2026 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Sale | 6,368 | $60.17 | $383,145 | |
| Aug 11, 2026 | GANNON STEVEN Director | Sale | 10,000 | $64.06 | $640,550 | |
| Mar 09, 2026 | MORTIMER IAN PRESIDENT & CEO | Sale | 43,348 | $59.26 | $2,568,802 | |
| Mar 09, 2026 | MORTIMER IAN PRESIDENT & CEO | Sale | 2,449 | $61.26 | $150,026 | |
| Mar 09, 2026 | MORTIMER IAN PRESIDENT & CEO | Sale | 10,072 | $60.47 | $609,054 | |
| Mar 09, 2026 | MORTIMER IAN PRESIDENT & CEO | Sale | 12,479 | $59.50 | $742,501 | |
| Mar 09, 2026 | MORTIMER IAN PRESIDENT & CEO | Sale | 21,515 | $60.49 | $1,301,442 | |
| Mar 09, 2026 | MORTIMER IAN PRESIDENT & CEO | Sale | 31,694 | $59.88 | $1,897,837 | |
| Mar 09, 2026 | MORTIMER IAN PRESIDENT & CEO | Sale | 65,000 | $62.06 | $4,033,900 | |
| Mar 09, 2026 | MORTIMER IAN PRESIDENT & CEO | Sale | 61,652 | $60.08 | $3,704,052 | |
| Mar 09, 2026 | MORTIMER IAN PRESIDENT & CEO | Sale | 21,791 | $58.81 | $1,281,529 | |
| Jan 02, 2026 | MORTIMER IAN PRESIDENT & CEO | Sale | 2,062 | $44.93 | $92,646 | |
| Jan 02, 2026 | MORTIMER IAN PRESIDENT & CEO | Sale | 37,938 | $44.40 | $1,684,447 | |
| Dec 08, 2025 | MORTIMER IAN PRESIDENT & CEO | Sale | 2,010 | $46.32 | $93,103 | |
| Dec 08, 2025 | MORTIMER IAN PRESIDENT & CEO | Sale | 8,820 | $45.59 | $402,104 | |
| Dec 05, 2025 | MORTIMER IAN PRESIDENT & CEO | Sale | 14,375 | $45.03 | $647,306 | |
| Nov 28, 2025 | MORTIMER IAN PRESIDENT & CEO | Sale | 97 | $45.01 | $4,366 | |
| Oct 01, 2025 | MORTIMER IAN PRESIDENT, CEO & INTERIM CFO | Sale | 25,000 | $40.16 | $1,004,000 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.